Neurodevelopmental outcome of extremely low birth weight infants with Candida infection.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Adams-Chapman Ira, Bann Carla M, Das Abhik, Goldberg Ronald N, Stoll Barbara J, Walsh Michele C, Sánchez Pablo J, Higgins Rosemary D, Shankaran Seetha, Watterberg Kristi L, Duara Shahnaz, Miller Nancy A, Heyne Roy J, Peralta-Carcelen Myriam, Goldstein Ricki F, Steichen Jean J, Bauer Charles R, Hintz Susan R, Evans Patricia W, Acarregui Michael J, Myers Gary J, Vohr Betty R, Wilson-Costello Deanne E, Pappas Athina, Vaucher Yvonne E, Ehrenkranz Richard A, McGowan Elisabeth C, Dillard Robert G, Fuller Janell, Benjamin Daniel K, Eunice Kennedy Shriver National Institutes of Child Health and Human Development Neonatal Research Network
Аннотация
STUDY DESIGN: ELBW infants born at Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network (NRN) centers between March 2004 and July 2007 who were screened for suspected sepsis were eligible for inclusion in the Candida study. Primary outcome data for neurodevelopmental impairment (NDI) or death were available for 1317 of the 1515 infants (87%) enrolled in the Candida study. The Bayley Scales of Infant Development-II or -III was administered at 18 months' adjusted age. A secondary comparison was performed with 864 infants enrolled in the NRN Generic Database during the same cohort who were never screened for sepsis and therefore not eligible for the Candida study.
RESULTS: Among ELBW infants enrolled in the Candida study, 31% with Candida and 31% with late-onset non-Candida sepsis had NDI at 18 months. Infants with Candida sepsis and/or meningitis had an increased risk of death and were more likely to have the composite outcome of death and/or NDI compared with uninfected infants in adjusted analysis. Compared with infants in the NRN registry never screened for sepsis, overall risk for death were similar but those with Candida infection were more likely to have NDI (OR 1.83, 95% CI 1.01-3.33, P = .047).
CONCLUSIONS: In this cohort of ELBW infants, those with infection and/or meningitis were at increased risk for death and/or NDI. This risk was highest among those with Candida sepsis and/or meningitis.